Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer

European Journal of Cancer Care

Volumn 18, Issue 2, 2009, Pages 191-194

  Kefeli, U ^a   Dane, F ^a   Yumuk, P F ^a   Karamanoglu, A ^a   Iyikesici, S ^a   Basaran, G ^a   Turhal, N S ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Catheterization; Catheters; Central venous; Heparin; Indwelling; Neoplasms; Venous thrombosis

Indexed keywords

FIBRINOLYTIC AGENT; HEPARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CASE CONTROL STUDY; CENTRAL VENOUS CATHETERIZATION; COMPARATIVE STUDY; FEMALE; HUMAN; INDWELLING CATHETER; MALE; MIDDLE AGED; NEOPLASM; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOSIS; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; CASE-CONTROL STUDIES; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 61349168584     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2008.00973.x     Document Type: Article

References (23)

1. Barbati A. Lucugnano D. (1997) Vascular access choice. Educational synopses in anesthesiology and critical care medicine. The Online Journal of Anesthesiology 2, 1080 3521.
2. Bern H.M., Lokich J.J., Wallach S.R., Bothe A., Benotti P.N., Arkin C.F., Greco F.A., Huberman M. Moore C. (1990) Very low dose of warfarin can prevent thrombosis in central venous catheters: a randomized, prospective trial. Annals of Internal Medicine 112, 423 428.
3. Boraks P., Seale J., Price J., Bass G., Ethell M., Keeling D., Mahendra P., Baglin T. Marcus R. (1998) Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. British Journal of Haematology 101, 483 486.
4. Central Venous Access Device Guideline Panel (2006) Managing Central Venous Access Devices in Cancer Patients: A Clinical Practice Guideline. Toronto (ON): Cancer Care Ontario (CCO); Sep 25. 39 p. (Evidence-based series; no. 16-1). Available at http://www.cancercare.on.ca/pdf/pebc16-1s.pdf
5. Dillon P.W., Jones G.R., Bagnall-Reeb H.A., Buckley J.D., Wiener E.S. Haase G.M. (2004) Prophylactic urokinase in the management of long-term venous access devices in children: a children's oncology group study. Journal of Clinical Oncology 22, 2718 2723.
6. Fan C.M. (1998) Tunneled catheters. Seminars in Interventional Radiology 15, 273 286.
7. Fraschini G., Becker M., Bruso P., Wang Z. Raber M. (1991) Comparative trial of urokinase versus heparin as prophylaxis for central venous ports. Proceedings American Journal of Social Clinical Oncology 10, 337 (abstr 1193).
8. Karamanoglu A., Yumuk P.F., Gumus M., Ekenel M., Aliustaoglu M., Selimen D., Sengoz M. Turhal N.S. (2003) Port needles: do they need not to be removed as frequently in infusional chemotherapy? Journal of Infusion Nursing 26, 239 242.
9. Karthaus M., Kretzschmar A., Kroning H., Biakhov M., Irwin D., Marschner N., Slabber C., Fountzilas G., Garin A., Abecasis N.G., Baronius W., Steger G.G., Sudhoff T., Giorgetti C. Reichardt P. (2006) Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Annals of Oncology 17, 289 296.
10. Mansfield P.F., Hohn D.C., Fornage B.D., Gerqurich M.A. Ota D.M. (1994) Complication and failure of subclavian-vein catheterization. New England Journal of Medicine 331, 1735 1738.
11. Massicotte P., Julian J.A., Gent M., Shields K., Marzinotto V., Szechtman B., Chan A.K., Andrew M. PROTEKT Study Group (2003) An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line related thrombotic complications in children: the PROTEKT study. Thrombosis Research 109, 101 108.
12. Mismetti P., Mille D., Laporte S., Charlet V., Buchmüller-Cordier A., Jacquin J.P., Fournel P., Dutrey-Dupagne C., Decousus H. CIP Study Group (2003) Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. Haematologica 88, 67 73.
13. Monreal M., Alastrue A., Rull M., Mira X., Muxart J., Rosell R. Abad A. (1996) Upper extremity deep venous thrombosis in cancer patients with venous access devices: prophylaxis with a low molecular weight heparin (Fragmin). Thrombosis Haemostosis 75, 251 253.
14. O'Grady N.P., Alexander M., Dellinger E.P., Gerberding J.L., Heard S.O., Maki D.G., Masur H., McCormick R.D., Mermel L.A., Pearson M.L., Raad I.I., Randolph A. Weinstein R.A. (2002) Guidelines for the prevention of intravascular catheter-related infections. Pediatrics 110, e51.
15. Pazdur R., Hoskins W.J., Coia L.R. Wagman L.D. (2005) Cancer management: a multidisciplinary approach. In : Medical, Surgical and Radiation Oncology, 9th edn, chapter 43 (ed. Povoski S.P pp. 935 946. CMP Healthcare Media, New York, USA.
16. Randolph A.G., Cook D.J., Gonzales C.A. Andrew M. (1998) Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest 113, 165 171.
17. Ray E., Shenroy S.S., McCarthy P.L., Broderick K.A. Kufman J.A. (1999) Weekly prophylactic urokinase instillation in tunneled central venous access devices. Journal of Vascular and Interventional Radiology 10, 1330 1334.
18. Scott W.L. (1998) Complications associated with central venous catheters. A survey. Chest 94, 1221 1224.
19. Solomon B., Moore J., Arthur C. Prince H.M. (2001) Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: a multicenter randomized comparison of urokinase versus heparin. European Journal of Cancer 37, 2379 2384.
20. Taber S.W. Bergamini T.M. (1997) Long-term venous access: indications and choice of site and catheter. Seminars in Vascular Surgery 10, 130 134.
21. Verso M. Agnelli G. (2003) Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. Journal of Clinical Oncology 21, 3665 3675.
22. Wickham R., Purl S. Welker D. (1992) Long-term central venous catheters: issues for care. Seminars in Oncology Nursing 8, 133 147.
23. Wiener E.S., McGuire P., Stolar C.J.H., Rich R.H., Albo V.C., Ablin A.R., Betcher D.L., Sitarz A.L., Buckley J.D. Krailo M.D. (1992) The CCSG prospective study of venous access devices: an analysis of insertions and causes for removal. Journal of Pediatric Surgery 27, 155 164.